117 related articles for article (PubMed ID: 18342887)
1. Characterization of ligand-binding properties of the human BMP type II receptor extracellular domain.
Yin H; Yeh LC; Hinck AP; Lee JC
J Mol Biol; 2008 Apr; 378(1):191-203. PubMed ID: 18342887
[TBL] [Abstract][Full Text] [Related]
2. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
[TBL] [Abstract][Full Text] [Related]
3. A host-guest relationship in bone morphogenetic protein receptor-II defines specificity in ligand-receptor recognition.
Yeh LC; Falcon WE; Garces A; Lee JC; Lee JC
Biochemistry; 2012 Sep; 51(35):6968-80. PubMed ID: 22894880
[TBL] [Abstract][Full Text] [Related]
4. The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.
Nickel J; Dreyer MK; Kirsch T; Sebald W
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S7-14. PubMed ID: 11263668
[TBL] [Abstract][Full Text] [Related]
5. High resolution structures of the bone morphogenetic protein type II receptor in two crystal forms: implications for ligand binding.
Mace PD; Cutfield JF; Cutfield SM
Biochem Biophys Res Commun; 2006 Dec; 351(4):831-8. PubMed ID: 17094948
[TBL] [Abstract][Full Text] [Related]
6. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II.
Kirsch T; Nickel J; Sebald W
EMBO J; 2000 Jul; 19(13):3314-24. PubMed ID: 10880444
[TBL] [Abstract][Full Text] [Related]
7. Folding and binding integrity of variants of a prototype ligand-binding module from the LDL receptor possessing multiple alanine substitutions.
Abdul-Aziz D; Fisher C; Beglova N; Blacklow SC
Biochemistry; 2005 Apr; 44(13):5075-85. PubMed ID: 15794645
[TBL] [Abstract][Full Text] [Related]
8. Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.
Kotzsch A; Nickel J; Seher A; Heinecke K; van Geersdaele L; Herrmann T; Sebald W; Mueller TD
J Biol Chem; 2008 Feb; 283(9):5876-87. PubMed ID: 18160401
[TBL] [Abstract][Full Text] [Related]
9. A single residue of GDF-5 defines binding specificity to BMP receptor IB.
Nickel J; Kotzsch A; Sebald W; Mueller TD
J Mol Biol; 2005 Jun; 349(5):933-47. PubMed ID: 15890363
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of BMP receptor synthesis by antisense oligonucleotides attenuates OP-1 action in primary cultures of fetal rat calvaria cells.
Yeh LC; Betchel KP; Lee JC
J Bone Miner Res; 1998 Dec; 13(12):1870-9. PubMed ID: 9844105
[TBL] [Abstract][Full Text] [Related]
11. BMPR-II is dispensable for formation of the limb skeleton.
Gamer LW; Tsuji K; Cox K; Capelo LP; Lowery J; Beppu H; Rosen V
Genesis; 2011 Sep; 49(9):719-24. PubMed ID: 21538804
[TBL] [Abstract][Full Text] [Related]
12. Identification of the ligand-binding site of the BMP type IA receptor for BMP-4.
Hatta T; Konishi H; Katoh E; Natsume T; Ueno N; Kobayashi Y; Yamazaki T
Biopolymers; 2000; 55(5):399-406. PubMed ID: 11241215
[TBL] [Abstract][Full Text] [Related]
13. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs.
Liu F; Ventura F; Doody J; Massagué J
Mol Cell Biol; 1995 Jul; 15(7):3479-86. PubMed ID: 7791754
[TBL] [Abstract][Full Text] [Related]
14. The solution structure of BMPR-IA reveals a local disorder-to-order transition upon BMP-2 binding.
Klages J; Kotzsch A; Coles M; Sebald W; Nickel J; Müller T; Kessler H
Biochemistry; 2008 Nov; 47(46):11930-9. PubMed ID: 18937504
[TBL] [Abstract][Full Text] [Related]
15. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5.
Nishitoh H; Ichijo H; Kimura M; Matsumoto T; Makishima F; Yamaguchi A; Yamashita H; Enomoto S; Miyazono K
J Biol Chem; 1996 Aug; 271(35):21345-52. PubMed ID: 8702914
[TBL] [Abstract][Full Text] [Related]
16. Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiation.
Liu H; Zhang R; Chen D; Oyajobi BO; Zhao M
J Cell Physiol; 2012 Mar; 227(3):952-63. PubMed ID: 21503889
[TBL] [Abstract][Full Text] [Related]
17. Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction.
Sebald W; Nickel J; Zhang JL; Mueller TD
Biol Chem; 2004 Aug; 385(8):697-710. PubMed ID: 15449706
[TBL] [Abstract][Full Text] [Related]
18. Alanine-scanning mutations of the BMP-binding domain of recombinant secretory bovine spp24 affect cytokine binding.
Sun A; Murray SS; Simon RJ; Jawien J; Behnam K; Miller TA; Brochmann EJ
Connect Tissue Res; 2010 Dec; 51(6):445-51. PubMed ID: 20615094
[TBL] [Abstract][Full Text] [Related]
19. BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors.
Allendorph GP; Isaacs MJ; Kawakami Y; Izpisua Belmonte JC; Choe S
Biochemistry; 2007 Oct; 46(43):12238-47. PubMed ID: 17924656
[TBL] [Abstract][Full Text] [Related]
20. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
